A Study of Investment Analysis of Selected Pharmaceutical Companies of India
Indian Pharmaceutical Industry is profoundly divided, with more than 20,000 enlisted organizations, with top 25
organizations controlling 70% approx. of the Indian market. The significant centre points of Indian Pharmaceutical
organizations are settled in Maharashtra, Gujarat, Andhra Pradesh, Himachal Pradesh (Baddi). 45% of the aggregate number
of assembling organizations is in Maharashtra and Gujarat. 70% of India's request is met by Indian Pharmaceutical Industry
as Bulk Drugs, Intermediates, Formulations, chemicals, tablets, cases, orals, infusions, powders, immunizations and so forth.
Indian Pharma industry was basically worked and controlled by overwhelming remote organizations – Multi National
Companies (MNCs), having backups in India because of accessibility of shoddy work and minimal effort. MNCs were
controlling very nearly 70% of Indian Market. The 1970 Indian Patent Act, propelled industry for vast size of generation of
mass medications. This prompted the change in the Industry. The imports of the medications got diminished, since;
indigenous medications began supplanting the same. This further prompted an expansion in utilization and extraordinary
development in definitions exercises. This development was led by the Indian organizations. Gradually however without a
doubt, MNCs began losing their mastery and a piece of the overall industry. Like some other industry, home-grown Pharma
industry is a blend of open and private endeavour.
Keywords - Pharmaceutical Industry, Investment Analysis, Ratio Analysis